These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 38022625)

  • 1. Unveiling the novel immune and molecular signatures of ovarian cancer: insights and innovations from single-cell sequencing.
    Li Z; Gu H; Xu X; Tian Y; Huang X; Du Y
    Front Immunol; 2023; 14():1288027. PubMed ID: 38022625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis.
    Yang B; Li X; Zhang W; Fan J; Zhou Y; Li W; Yin J; Yang X; Guo E; Li X; Fu Y; Liu S; Hu D; Qin X; Dou Y; Xiao R; Lu F; Wang Z; Qin T; Wang W; Zhang Q; Li S; Ma D; Mills GB; Chen G; Sun C
    Cell Rep Med; 2022 Dec; 3(12):100856. PubMed ID: 36543113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfolding the mysteries of heterogeneity from a high-resolution perspective: integration analysis of single-cell multi-omics and spatial omics revealed functionally heterogeneous cancer cells in ccRCC.
    Zheng J; Lu W; Wang C; Chen S; Zhang Q; Su C
    Aging (Albany NY); 2024 Jun; 16(13):10943-10971. PubMed ID: 38944814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing reveals that MYBL2 in malignant epithelial cells is involved in the development and progression of ovarian cancer.
    Shao W; Lin Z; Xiahou Z; Zhao F; Xu J; Liu X; Cai P
    Front Immunol; 2024; 15():1438198. PubMed ID: 39136009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burgeoning spatial multi-omics in human gastrointestinal cancers.
    Liang W; Zhu Z; Xu D; Wang P; Guo F; Xiao H; Hou C; Xue J; Zhi X; Ran R
    PeerJ; 2024; 12():e17860. PubMed ID: 39285924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights from spatial transcriptome analysis in solid tumors.
    Du J; An ZJ; Huang ZF; Yang YC; Zhang MH; Fu XH; Shi WY; Hou J
    Int J Biol Sci; 2023; 19(15):4778-4792. PubMed ID: 37781515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer.
    Fu Y; Tao J; Liu T; Liu Y; Qiu J; Su D; Wang R; Luo W; Cao Z; Weng G; Zhang T; Zhao Y
    Mol Cancer; 2024 Jul; 23(1):140. PubMed ID: 38982491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial multi-omics: deciphering technological landscape of integration of multi-omics and its applications.
    Liu X; Peng T; Xu M; Lin S; Hu B; Chu T; Liu B; Xu Y; Ding W; Li L; Cao C; Wu P
    J Hematol Oncol; 2024 Aug; 17(1):72. PubMed ID: 39182134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer beyond imaging: integration of AI and multiomics biomarkers.
    Hatamikia S; Nougaret S; Panico C; Avesani G; Nero C; Boldrini L; Sala E; Woitek R
    Eur Radiol Exp; 2023 Sep; 7(1):50. PubMed ID: 37700218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
    Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
    Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.
    Chen J; Yuan Q; Guan H; Cui Y; Fu C; Wei T; Liu K
    Front Immunol; 2024; 15():1461424. PubMed ID: 39346916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elucidating the multifaceted role of MGAT1 in hepatocellular carcinoma: integrative single-cell and spatial transcriptomics reveal novel therapeutic insights.
    Li Y; Chen Y; Wang D; Wu L; Li T; An N; Yang H
    Front Immunol; 2024; 15():1442722. PubMed ID: 39081317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of single-cell sequencing to the research of tumor microenvironment.
    Chen S; Zhou Z; Li Y; Du Y; Chen G
    Front Immunol; 2023; 14():1285540. PubMed ID: 37965341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel protein-based prognostic signature linked to immunotherapeutic efficiency in ovarian cancer.
    Chen SF; Wang LY; Lin YS; Chen CY
    J Ovarian Res; 2024 Sep; 17(1):190. PubMed ID: 39342345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unveils heterogeneity and establishes a novel signature for prognosis and tumor immune microenvironment in ovarian cancer.
    Wang Z; Zhang J; Dai F; Li B; Cheng Y
    J Ovarian Res; 2023 Jan; 16(1):12. PubMed ID: 36642706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer-specific dysregulated genes with prognostic significance: scRNA-Seq with bulk RNA-Seq data and experimental validation.
    Liu C; Zhang Y; Li X; Wang D
    Ann N Y Acad Sci; 2022 Jun; 1512(1):154-173. PubMed ID: 35247207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in single-cell omics and multiomics for high-resolution molecular profiling.
    Lim J; Park C; Kim M; Kim H; Kim J; Lee DS
    Exp Mol Med; 2024 Mar; 56(3):515-526. PubMed ID: 38443594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unveiled mosaic of intra-tumor heterogeneity in ovarian cancer through spatial transcriptomic technologies: A systematic review.
    Masatti L; Marchetti M; Pirrotta S; Spagnol G; Corrà A; Ferrari J; Noventa M; Saccardi C; Calura E; Tozzi R
    Transl Res; 2024 Nov; 273():104-114. PubMed ID: 39111726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
    Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
    Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.